During the plenary session on the first day of the fall meeting of the National Association of Accountable Care Organizations, CMS' Sean Cavanaugh discussed the outcomes of the Medicare ACO programs and members of 2 successful ACOs joined him on stage to provide their input.
Despite some skeptical coverage of the most recent results of the Medicare accountable care organization (ACO) program, these results are actually heartening, said Sean Cavanaugh, deputy administration and director of the Center for Medicare at CMS.
During the plenary session on the first day of the fall meeting of the National Association of ACOs, Cavanaugh discussed the outcomes of the Medicare ACO programs and members of 2 successful ACOs joined him on stage to provide their input.
While coverage of the most recent results of the Medicare ACO programs reported that fewer than one-third (31%) of ACOs generated shared savings, Cavanaugh said that he found the results heartening after drilling deeper into the data. For example, every cohort has, on average, improved year to year.
“The longer an ACO is in the program, the better they do on quality,” he said.
So while just 31% of all ACOs participating shared in savings, the reality was that the newer ACOs were “diluting the successes” of the older ones. Of the ACOs that started the program in 2012, 42% shared in savings, which is a big difference, he pointed out.
“I think that’s a very different narrative on this program,” he said, adding that perhaps expectations needed to be slightly altered.
“ACOs that are 1 or 2 years old, maybe we shouldn’t expect big things from them yet,” he said.
Beneficiary attestation is another area CMS is looking to address, Cavanaugh said. The agency is proposing to move forward with some way for a beneficiary to say that he or she wants to be attributed to a specific doctor, regardless of what is on the claims and the doctor’s ACO.
Jeff Spight, of Universal American, followed Cavanaugh to discuss why some ACOs see success. The biggest reason is the relationships and the work of physicians and their staff.
“This is a behavioral change, a cultural change,” Spight said.
The Medicare ACO programs are entering an interesting phase, he said, because for a long time it has all been an experiment or a pilot to test things out. However, it is now time to pivot away from that thinking to become a permanent part of the healthcare delivery system.
“ACOs are not going anywhere,” Spight said. “We need to figure out how we make ourselves a permanent part of [healthcare delivery]. Stop talking about it like it’s something that is potentially going to go away. We are here to stay.”
Ultimately, it is up to the ACOs to do a better job of marketing what they do and the changes they are making for the good of the ACO program.
Changing is essential for ACOs, David Klebonis of Doctors ACO said. The business of an ACO should be changing if an ACO wants to succeed.
“If you change nothing, your payment is very precise: it’s nothing,” Klebonis said.
Changing the business means doing a better job of getting physicians engaged, because many ACOs have some physicians that have changed their practice, but many others that have done nothing. The ACO needs to address those physicians and find out what the ACO needs to do to help foster a change in a physician’s behavior.
Klebonis echoed the previous comments from Cavanaugh and Spight, who both said that ACO successes need to be promoted better in order to combat the negative propaganda facing the program.
Cavanaugh and CMS remain supporters of the Medicare ACO program. “We feel that there has been a lot of misunderstanding about how the program works from skeptics, but that the program is genuinely working,” he said.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Value-Based Care Is Key to Bringing Cardiology Breakthroughs to Those Who Will Benefit Most
March 13th 2025On December 10, 2024, cardiologists, researchers, and value-based care experts gathered in Dallas, Texas, to discuss best practices for implementing advances in cardiology care with a value-based mindset, spanning the care continuum from prevention to treatment.
Read More
A Focus on MAHA, Lasting Changes to Health Care Programs for Trump’s Second Term
March 13th 2025The second Trump administration is expected to bring changes to Medicaid, Medicare Advantage, and the health insurance exchanges, as well as highlight the Make America Healthy Again (MAHA) movement, speakers at the Value-Based Insurance Design Summit said.
Read More